Drug Screening Market Revenue, Region, Country, and Segment Analysis

Drug Screening Market

Drug Screening Industry Overview

The global drug screening market is projected to reach USD 11.6 billion in 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period. Rising drug and alcohol consumption, strict enforcement of laws mandating drug and alcohol testing, government funding for key markets, regulatory approvals and product and service launches are key factors driving the growth of this market.

Gather more insights about the market drivers, restrains and growth of the Global

Drug Screening Market Segmentation

MarketsandMarkets has segmented the Drug Screening market on the basis of application, end user, and region:

Services segment is expected to grow at the highest CAGR during the forecast period.

Based on service and product, the drug screening market is segmented into services and products. The services segment accounted for the largest share of 57.4%  of the drug screening market

Analytical instruments are expected to dominate the drug screening products market

Based on the product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. the analytical segment is expected to dominate the market with a share of 53.0%. The high growth in this segment is owing to their recurring requirement and repetitive usage.

Based on the sample type, the urine sample segment is accounted for the largest share of the drug screening market.

By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. Among these, the urine sample segment is expected to account for the largest share of 61.5%

Drug Screening Market Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Market Share Insights

  • In August 2021, Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.

Key Companies Profile

The industry is marked by the presence of various large- and small-scale businesses operators. The market is highly competitive and dominated by key participants that focus on executing innovative strategies like mergers and acquisitions, market penetration, partnerships, and distribution agreements to increase their revenue.

Some prominent players in the global Drug Screening market include,

Abbott Laboratories (US), Thermo Fisher Scientific (US), Quest Diagnostics (US), Alfa Scientific Designs (US), Roche (Switzerland), OraSure Technologies (US), MPD Inc. (US), and Shimadzu (Japan)

Order a free sample PDF of the Infectious Disease Diagnostics Market Intelligence Study, published by MarketsandMarkets

Comments are closed